Company news

PYC Therapeutics Limited news in 2020

PYC Therapeutics Limited's news releases, calls and decks from 2020, newest first.

View company

Visual Evidence of Lead Drugs Efficacy

December 15, 2020

Review of Activities and Appendix 4C

October 26, 2020

Successful Institutional Entitlement Offer and Placement

October 21, 2020

PYC Business and Equity Raising Presentation

October 19, 2020

PYC Equity Raising to Raise up to $55 Million

October 19, 2020

New Drug for Substantial Unmet Need Added to Pipeline

October 11, 2020

PYCs Lead Drug Effective in Patient Derived Models Tested

October 6, 2020

Second Potential Blockbuster Drug Added to PYCs Pipeline

October 4, 2020

Creation of Novel Gene Therapy Delivery Technology

September 7, 2020

Appendix 4E Preliminary Final Report

August 31, 2020

Executive re-structure across global operations

August 19, 2020

Shareholder Update - Forward View 2020 Milestones

August 4, 2020

June 2020 Quarterly Activity Report and Cashflow

July 30, 2020

Successful Dose Response & Toxicity Studies in Lead Program

July 21, 2020

S&P DJI Announces June 2020 Quarterly Rebalance

June 11, 2020

March 2020 Quarterly Activities and Cash Flow Report

April 29, 2020

Successful Efficacy Result on Path to First in Human Studies

March 31, 2020

Investor Presentation - February 2020

February 23, 2020

CEO Appointment and Establishment of US Office

February 12, 2020

Expansion Of Drug Development Pipeline

February 2, 2020

Appendix 4C - quarterly

January 31, 2020

Quarterly Shareholder Update

January 5, 2020

Decks in 2020